Company Number: 15359340

Analysis Date: 2025-07-20 14:08 UTC

Financial Health Assessment for DIMYTEK LTD

---

1. Financial Health Score: D

Explanation:
DIMYTEK LTD is a very young company, incorporated in December 2023, with minimal financial activity reflected in its first accounting period ending December 2024. The net current assets are marginally positive at £17, indicating a very thin buffer between current assets and liabilities. The overall financial position is fragile, resembling a "patient" just admitted and yet to stabilize. Given these limited financials and the lack of operational history, the company’s financial health is currently weak but survivable with careful management.

---

2. Key Vital Signs (Critical Metrics)

Metric	Value (£)	Interpretation
Current Assets	2,626	Very low; mostly debtors (accounts receivable)
Current Liabilities	2,609	Almost equal to current assets; tight liquidity
Net Current Assets	17	Barely positive working capital; "healthy cash flow" absent
Net Assets (Equity)	17	Minimal shareholder funds; the "immune system" is weak
Share Capital	1	Minimal initial capital injection
Retained Earnings (P&L Reserve)	16	Small accumulated profit or retained funds
Employees	3	Small team consistent with micro/small business
Turnover (Not disclosed)	Not provided	Unknown revenue generation, a key missing vital sign

---

3. Diagnosis: What the Financial Data Reveals About Business Health

• Liquidity Status: The company exhibits a "symptom of distress" in liquidity management. With current assets almost entirely made up of debtors (£2,626) and current liabilities nearly the same (£2,609), the company’s working capital is marginally positive by only £17. This very narrow margin indicates that the company may struggle to meet short-term obligations if any unexpected expenses arise.

• Capital Structure: The company has a nominal equity base (£17), reflecting an early-stage startup with initial share capital of just £1. This minimal capitalization puts the company at risk if operational losses occur or if cash flow worsens.

• Operational Health: The absence of turnover data and the very short trading period limit insight into operational performance. The company is classified under SIC code 94990 (membership organizations not elsewhere classified), which may imply limited commercial activity or early development phases.

• Risk Factors:

  • High dependency on receivables: The current assets are almost exclusively debtors, which could be a risk if collection is delayed or defaults occur.
  • No audit requirement due to small company exemption, so financial scrutiny is limited at this stage.
  • Single director and sole shareholder control may centralize decision-making but can also mean limited governance oversight.

• Overall Condition: The company is in a "critical early phase," akin to a patient in observation with only minimal vital signs recorded. The financial "immune system" (shareholders' funds) is very limited, and liquidity is fragile. There are no overt signs of insolvency but also no clear indicators of robust financial health or growth.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

1. Enhance Liquidity Management:

   • Aim to increase cash or cash equivalents to build a buffer beyond receivables.
   • Monitor debtor collections closely to avoid cash flow bottlenecks.

2. Increase Capital Base:

   • Consider additional share capital injection or external funding to strengthen equity and provide financial resilience.

3. Develop Revenue Streams:

   • Focus on generating turnover and converting receivables into cash promptly to improve operational cash flow.
   • Track sales and profit margins carefully to detect early symptoms of operational inefficiency.

4. Implement Financial Controls:

   • Even as a small entity, maintain robust financial record-keeping and budgeting to anticipate liquidity crunches.
   • Explore the benefits of voluntary audit or independent financial review to enhance confidence with stakeholders.

5. Governance and Oversight:

   • Consider expanding management oversight or advisory support to provide financial and strategic guidance during this critical growth phase.

---